Abstract
Several new sustained-release formulations of theophylline were developed and their sustained-release performance was evaluated in a comparative pharmacokinetic analysis. These new formulations, Theo-Dur, Theotrim and aminophylline were administered to 5 dogs and 6 healthy volunteers. Plasma levels of theophylline were determined by an HPLC assay. The absorption profiles of the various formulations were analyzed pharmacokinetically, using the Wagner-Nelson procedure. Two new formulations, Theotrim and Theo-Dur demonstrated very good sustained-release performance in humans and dogs. One formulation (T-2-A) showed incomplete absorption in both species, and its bioavailability relative to aminophylline was about 65% in humans and 78% in dogs. These results were also confirmed by the Wagner-Nelson Procedure. In this study the dog was found to be a good animal model as far as the rate and extent of absorption of the various tested theophylline formulations were concerned; the dog may be useful in primary screening of new formulations from this series.
| Original language | English |
|---|---|
| Pages (from-to) | 97-102 |
| Number of pages | 6 |
| Journal | International Journal of Pharmaceutics |
| Volume | 37 |
| Issue number | 1-2 |
| DOIs | |
| State | Published - Jun 1987 |
Keywords
- Animal model
- Pharmacokinetics
- Sustained-release dosage form
- Theophylline
Fingerprint
Dive into the research topics of 'Comparative pharmacokinetic evaluation of sustained-release theophylline formulations in dogs and humans'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver